Robert Grubb to Incidence
This is a "connection" page, showing publications Robert Grubb has written about Incidence.
Connection Strength
0.341
-
The REDUCE Follow-Up Study: low rate of new prostate cancer diagnoses observed during a 2-year, observational, followup study of men who participated in the REDUCE trial. J Urol. 2013 Mar; 189(3):871-7.
Score: 0.076
-
High-grade prostate cancer in the Prostate Cancer Prevention Trial: fact or artifact? J Natl Cancer Inst. 2007 Sep 19; 99(18):1355-6.
Score: 0.053
-
Extended follow-up for prostate cancer incidence and mortality among participants in the Prostate, Lung, Colorectal and Ovarian randomized cancer screening trial. BJU Int. 2019 05; 123(5):854-860.
Score: 0.029
-
Sexually transmitted infections, benign prostatic hyperplasia and lower urinary tract symptom-related outcomes: results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. BJU Int. 2016 Jan; 117(1):145-54.
Score: 0.023
-
Physical activity and benign prostatic hyperplasia-related outcomes and nocturia. Med Sci Sports Exerc. 2015 Mar; 47(3):581-92.
Score: 0.022
-
The safety of aeroplane travel in patients with symptomatic carotid occlusion. J Neurol Neurosurg Psychiatry. 2014 Apr; 85(4):435-7.
Score: 0.021
-
Predicting risk of bladder cancer using clinical and demographic information from prostate, lung, colorectal, and ovarian cancer screening trial participants. Cancer Epidemiol Biomarkers Prev. 2013 Dec; 22(12):2241-9.
Score: 0.020
-
Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. J Natl Cancer Inst. 2012 Jan 18; 104(2):125-32.
Score: 0.018
-
Population based analysis of the increasing incidence of kidney cancer in the United States: evaluation of age specific trends from 1975 to 2006. J Urol. 2012 Jan; 187(1):32-8.
Score: 0.018
-
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet. 2010 Nov; 42(11):978-84.
Score: 0.017
-
Effect of reclassification on the incidence of benign and malignant renal tumors. J Urol. 2010 Feb; 183(2):455-8.
Score: 0.016
-
Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009 Mar 26; 360(13):1310-9.
Score: 0.015
-
Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Causes Control. 2008 Dec; 19(10):1267-76.
Score: 0.014